Cytoreductive nephrectomy for metastatic RCC in the era of targeted therapy

Abstract

Metastatic renal cell carcinoma (RCC) has traditionally been associated with a poor prognosis with few effective treatments. In the multimodal treatment of metastatic RCC, cytoreductive nephrectomy (CN) became the standard of care after two randomized trials demonstrated a benefit in overall survival in patients who received CN prior to treatment with… (More)
DOI: 10.1038/nrurol.2009.102

Topics

3 Figures and Tables

Slides referencing similar topics